Arrowhead Research (ARWR) Selloff Unwarranted - Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
Go back to Arrowhead Research (ARWR) Selloff Unwarranted - Jefferies
October 8, 2014 5:41 PM EDT
RBC Capital downgraded Arrowhead Research (NASDAQ: ARWR) from Outperform to Sector Perform with a price target of $9.00 (from $35.00). The change follows the release of its AASLD abstract earlier.
Analyst Michael J. Yee said, "Although the stock is down significantly to ~$350M mkt cap now because of low-end efficacy in AASLD abstract, we find it reasonable to now... More
October 8, 2014 1:16 PM EDT
Deutsche Bank maintained a Buy rating on Arrowhead Research (NASDAQ: ARWR) but lowered its price target to $20.00 (from $45.00). Earlier Arrowhead Research reported disappointing ARC-520 data in a AASLD abstract. Analyst Alethia Young sees higher risks but doesn't think the program is dead.
"The viral reductions w/ ARC-520... More
